The safety and security of medical devices driven by software, the software-development processes, and the need for data collection and privacy, all offer challenges and opportunities for device regulation and clinical care.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Adversarial attacks and adversarial robustness in computational pathology
Nature Communications Open Access 29 September 2022
-
Multinational landscape of health app policy: toward regulatory consensus on digital health
npj Digital Medicine Open Access 11 May 2022
-
Beyond validation: getting health apps into clinical practice
npj Digital Medicine Open Access 03 February 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fu K. in Public Health Effectiveness of the FDA 510(k) Clearance Process: Measuring Postmarket Performance and Other Select Topics: Workshop Report (ed. Wizemann, T.) Appendix D (Nat. Acad. Press, 2011).
Software as a Medical Device Working Group. Software as a Medical Device (SAMD): Clinical Evaluation (IMDRF, 2017).
CDRH. Digital Health Innovation Action Plan (FDA, 2019).
Shuren, J., Patel, B. & Gottlieb, S. JAMA 320, 337–338 (2018).
Directive 2007/47/EC of the European Parliament and of the Council (Official Journal of the European Union, 2007).
Software as a Medical Device Working Group. Software as a Medical Device (SAMD): Key Definitions (IMDRF, 2013).
Developing a Software Precertification Program: A Working Model (v.1 - April 2018) (FDA, 2018).
Digital Health Criteria (FDA, 2018); https://go.nature.com/2Zoi4qJ
H. R.34 - 21st Century Cures Act (114th US Congress, 2015–2016).
Precertification (Pre-Cert) Pilot Program: Frequently Asked Questions (FDA, 2019); https://go.nature.com/2MKukAt
McHugh, M. et al. in Software Process Improvement and Capability Determination (eds Woronowicz T. et al.) 199–210 (Springer, 2013).
McHugh, M., Cawley, O., McCaffery, F., Richardson, I. & Wang, X. In Proc. 5th International Workshop on Software Engineering in Health Care (eds Knight, J. & Kuziemsky, C.) 12–19 (IEEE Press, 2013).
McHugh, M., McCaffery, F. & Casey, V. in Software Process Improvement and Capability Determination (eds Mas, A. et al.) 141–147 (Springer, 2012).
IEC 62304:2006 Medical device software -- Software life cycle processes (International Organization for Standardization, 2006).
Program - International Workshop on Software Engineering in Healthcare Systems (Lero, 2018).
International Conference on Healthcare Informatics (IEEE, 2019); http://www.ieee-ichi.org/
Medical Device Recalls: K150910 (FDA, accessed 18 July 2018; https://go.nature.com/2IbD2mU
Class 2 Device Recall AccuChek Connect Diabetes Management App (FDA, accessed 18 July 2018); https://go.nature.com/2Rc0TFL
Ronquillo, J. G. & Zuckerman, D. M. Milbank Q 95, 535–553 (2017).
Hospira Symbiq Infusion System Vulnerability Advisory ICSA-15-174-0 (ICS-CERT, 2018).
Liu, V., Musen, M. A. & Chou, T. JAMA 313, 1471–1473 (2015).
Microsoft Security Bulletin MS17-010 - Critical (Microsoft, 2017).
Deciding When to Submit a 510(k) for a Software Change to an Existing Device: Guidance for Industry and Food and Drug Administration Staff (FDA, 2017).
Schaeffer, N. E., Parks, L. J., Verhoef, E. T., Morgan, C. A. & Stal, M. J. Diabetes Sci. Technol. 10, 453–456 (2015).
Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health (FDA, 2018).
Wimmer, N. J. et al. J. Health Care Finance 2016 Summer2016 (Spec Features, 2017).
Bates, D. W., Saria, S., Ohno-Machado, L., Shah, A. & Escobar, G. Health Aff. 33, 1123–1131 (2014).
Ghassemi, M., Celi, L. A. & Stone, D. J. Crit. Care 19, 118 (2015).
Parikh, R. B., Kakad, M. & Bates, D. W. JAMA 315, 651–652 (2016).
Henry, K. E., Hager, D. N., Pronovost, P. J. & Saria, S. Sci. Transl Med. 7, 299ra122 (2015).
Ram, S., Zhang, W., Williams, M. & Pengetnze, Y. IEEE J. Biomed. Health Inform. 19, 1216–1223 (2015).
Chen, J. H. & Asch, S. M. N. Engl. J. Med. 376, 2507–2509 (2017).
Jiang, F. et al. Stroke Vasc. Neurol. 2, 230–243 (2017).
Resnic, F. S. & Matheny, M. E. N. Engl. J. Med. 378, 595–597 (2018).
Sherman, R. E. et al. N. Engl. J. Med. 375, 2293–2297 (2016).
Budrionis, A. & Bellika, J. G. J. Biomed. Inform. 64, 87–92 (2016).
Apple announces effortless solution bringing health records to iPhone (Apple, 2018).
CMS & HHS. Fed. Regist. 80, 62761–62955 (2015)..
Access of individuals to protected health information 45 CFR § 164.524 (HSS, 2016).
Lee, T. T. & Kesselheim, A. S. Ann. Intern. Med. 168, 730–732 (2018).
FDA’s Sentinel Initiative (FDA, 2018).
National Evaluation System for Health Technology (NEST) (FDA, 2019).
Anand, S. S. et al. JAMA Cardiol. 1, 601–606 (2016).
Chan, Y.-F. Y. et al. Nat. Biotechnol. 35, 354–362 (2017).
Semigran, H. L., Linder, J. A., Gidengil, C. & Mehrotra, A. BMJ 351, h3480 (2015).
Redfern, J. et al. BMJ 4, e004523 (2014).
Sepah, S. C., Jiang, L. & Peters, A. L. J. Med. Internet. Res. 17, e92 (2015).
Firth, J. et al. World Psych. 16, 287–298 (2017).
Gottlieb, S. Twitter (11 April 2018); https://go.nature.com/2ZjyGzJ
Comstock, J. MobiHealthNews (23 March 2016); https://go.nature.com/2KcJSe9
FDA approves pill with sensor that digitally tracks if patients have ingested their medication. FDA (13 November 2017).
Healthy Innovation, Safer Families: FDA’s 2018 Strategic Policy Roadmap (FDA, 2018).
Acknowledgements
The authors are grateful to F. Hillen, T. Wang, B. Eskofier and J. Kumar for helpful comments.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary Information
Rights and permissions
About this article
Cite this article
Gordon, W.J., Stern, A.D. Challenges and opportunities in software-driven medical devices. Nat Biomed Eng 3, 493–497 (2019). https://doi.org/10.1038/s41551-019-0426-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-019-0426-z
This article is cited by
-
Device integration of electrochemical biosensors
Nature Reviews Bioengineering (2023)
-
Multinational landscape of health app policy: toward regulatory consensus on digital health
npj Digital Medicine (2022)
-
Adversarial attacks and adversarial robustness in computational pathology
Nature Communications (2022)
-
Beyond validation: getting health apps into clinical practice
npj Digital Medicine (2020)